1,084
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic

ORCID Icon
Pages 1289-1299 | Received 18 Jul 2022, Accepted 01 Nov 2022, Published online: 29 Nov 2022

Figures & data

Table 1. Participant characteristics.

Figure 1. Self-efficacy scale for community pharmacists about their own and other pharmacists’ ability to identify and manage SFs.

Figure 1. Self-efficacy scale for community pharmacists about their own and other pharmacists’ ability to identify and manage SFs.

Figure 2. Major themes on how can falsified medicines reaching the public be reduced.

Figure 2. Major themes on how can falsified medicines reaching the public be reduced.

Table 2. Descriptive statistics of respondent within 20-minute walk time. Standard deviation (STD), currency represented in Great British Pounds (GBP), and quintiles are 1/5 segments of the population.

Table 3. Index of multiple deprivation decile 2019 scores for (n = 195) live postcodes; deprivation affecting older people index (IDAOPI), income deprivation affecting children index (IDACI).

Table 4. Crosstabulation of deprivation decile against whether SFs were detected.

Supplemental material

Supplementary_file_3_Comment_what_role_can_pharmacists_play_in_combating_SFs.pdf

Download PDF (119.6 KB)

Supplementary_file_2_Comment_how_can_SFs_reaching_the_public_be_reduced.pdf

Download PDF (120.8 KB)

Supplementary_file_1_Syntax.pdf

Download PDF (68.5 KB)

Data availability statement

All data generated or analyzed during this study are included in this published article (and its supplementary information files).